Cost-Effective Interventions for HIV, Malaria, ...

By Rene Pretorius

April 14, 2025

Limited healthcare budgets demand smart investments. Low- and middle-income countries battle HIV/AIDS, malaria, syphilis, and tuberculosis. A recent
Balancing Pandemic Preparedness Priorities and Military Spending
Exploring the MASLD CKD Socioeconomic Link
Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefit...
HPV Testing in Head and Neck Squamous Cell Carcinoma
Neoadjuvant Chemoimmunotherapy HNSCC in Advanced HPV-Negative Patients
Advancing Heart Transplantation: The Role of the Lumped Parameter Model
Nano-Radiopharmaceuticals for Colon Cancer Treatment
HIV Colorectal Cancer Survival
Global Initiative Launches Access to Essential Childhood Cancer Medicines
Survival Benefits of Immune Checkpoint Inhibitors in Metastatic Colorectal Ca...
FDA Warning Aspen Pharmacare: Evaluating Compliance Violations and Their Impact
Pharmaceutical Innovation and Market Access: Insights from Fast Company’s 202...